Host Raymond Cross, MD, discusses the updates in the American College of Gastroenterology guideline on managing ulcerative colitis with first author David Rubin, MD.
Dr Regueiro reviews three major abstracts from Cleveland Clinic presented at DDW 2025 on postoperative Crohn's disease, including biomarker monitoring, the effect of previous anti-TNF exposure, and biologic therapy for older patients.
Dr Cross discusses the key points from his address at the AIBD regional meeting in Chicago on how to choose the best therapies for patients with IBD by assessing disease severity, disease activity, extraintestinal manifestations and more.